TKT Brings Back Astrue; Legal, Political Focus Suggests New Biotech Model
Executive Summary
Transkaryotic Therapies is bringing back Michael Astrue to head a turnaround effort as the company looks to recover from a recent series of adverse regulatory and judicial decisions